Currently, a clinical trial is in progress to assess the effectiveness of CAR-T cell therapy when used alongside PD-1/PD-L1 inhibitors in patients with hepatocellular carcinoma (175). This evidence concerns the gene CD274 and hepatocellular carcinoma.